At a glance
ClinicalIndex Comparison RecordN/ACompleted· 74 enrolled
Drug / intervention
Avéli devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CONtrolled Focal Fibrous Band Release Method Study
In Brief
A clinical study evaluating Avéli device for Cellulite. Completed, enrolled 74 participants across 9 sites in 2 countries.
Detailed Summary
Study to evaluate the safety and effectiveness of the Avéli medical device to reduce the appearance of cellulite.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCellulite
CountriesAustralia, United States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJan 2021
First PostedFeb 2021
Primary CompletionJun 2021
Study CompletionMar 2022
TodayJul 2026
First PostedFeb 8, 2021
Enrollment StartJan 7, 2021
Primary CompletionJun 14, 2021
Study CompletionMar 4, 2022
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 5.4 years ago
Interventions
Avéli devicedevice
Minimally invasive single procedure with the Avéli device for reduction in the appearance of cellulite in the thighs and buttocks.